FinTechFunding

Race Oncology: Secures human ethics trial approval

Race Oncology Secures human ethics trial approval

  • Race Oncology (RAC) receives human ethics approval for the next stage of its clinical trial of Zantrene in breast cancer patients
  • The company received the approval from the Hunter New England Human Research Ethics Committee for the observational stage of a planned phase 1/2b cardioprotection clinical program using Zantrene
  • The company must now submit and receive research institutional governance approval before patients can be enrolled and treated in the study
  • Race says the human trials will be fully funded from its December 2021 capital raise
  • RaceOncology is up 3.99 per cent, trading at $1.96 at 2:51 pm AEDT
Previous article
Floodbase: Raises $12M in Series A funding
Next article
Stripe & Amazon: Partnership accelerates ecommerce and streamlines online payments
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

FedNow Strengthens Instant Payments Security with New API Tool

New API tool enhances security for immediate digital transactions in the U.S.Highlights: FedNow introduces a new API tool...
FinTech

UK Government Strengthens Talks with Anthropic for Mythos Release Amid Concerns

Anthropic's AI technology under scrutiny as UK seeks to enhance regulatory framework.Highlights: UK government engages Anthropic for AI...
FinTech

Salmon Strengthens Fundraising for Philippines Expansion

Fintech company Salmon secures new funding to enhance its operations in the Philippines.Highlights: Salmon raises significant funds to...
FinTech

Truist Pilots Zelle Bill Payments, Strengthening Digital Banking Services

New pilot program aims to simplify bill payments through Zelle for customers.Highlights: Truist launches pilot program for Zelle...